Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2015Investigative Ophthalmology & Visual Science

Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes

View Full Paper
Ask AI
Bookmark
Share

Authors

YNYuichi NiwaMKMasashi KakinokiShiga University of Medical ScienceTSTomoko SawadaShiga University of Medical Science

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Niwa et al. (2015) studied this question.

synapsesocial.com/papers/6aae52cb2335b257170d8628https://doi.org/10.1167/iovs.15-17279
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intraocular Pharmacokinetics of Ranibizumab in Vitrectomized Versus Nonvitrectomized Eyes2014 · 110 citations
  2. 2Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration2005 · 502 citations
  3. 3Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 years' outcome2008 · 49 citations
  4. 4Pharmacokinetics of Bevacizumab and Its Effect on Vascular Endothelial Growth Factor after Intravitreal Injection of Bevacizumab in Macaque Eyes2010 · 124 citations
  5. 5Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes2013 · 86 citations